SHARES OF MOONLAKE IMMUNOTHERAPEUTICS SURGE 17% AFTER FT REPORTS MERCK HELD TALKS TO BUY CO FOR OVER $3 BLN

Reuters · 06/03 13:40

Please log in to view news